Antibodies under a microscope

DHH28808

Research Grade Sonelokimab

Description

Bispecific, Trivalent, M-1095, MSB-0010841, CAS: 1414386-05-2

Targets

CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, IL17F, Interleukin-17F, IL-17F, Cytokine ML-1, ALB, Albumin

Isotype/Mimetic

VH-VH'-VH

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression